Literature DB >> 21461650

Subcutaneous sarcoidosis: report of two cases and review of the literature.

Camilla Dalle Vedove1, Chiara Colato, Giampiero Girolomoni.   

Abstract

Sarcoidosis is a multisystemic disease with cutaneous lesions present in about one fourth of patients. Cutaneous lesions may be specific or nonspecific based on the presence or the absence of sarcoidal granulomas. Subcutaneos sarcoidosis is the less frequent of the specific cutaneous lesions of sarcoidosis. We report here 2 new cases and review 83 cases reported in literature of subcutaneous sarcoidosis. Subcutaneous sarcoidosis present usually with asymptomatic firm nodules covered by normal-appearing skin, mostly on the forearms and legs. Diagnosis may require a high index of suspicion. In the vast majority of patients, subcutaneous nodules were the manifestation that allowed the diagnosis of systemic sarcoidosis. There is a strong association between subcutaneous sarcoidosis and bilateral hilar lymphadenopathy (72.7%). About 15% of patients have in order of frequency uveitis, parotitis, arthritis, mucositis, dactylitis, neurological and renal involvement, hepatosplenomegaly.

Entities:  

Mesh:

Year:  2011        PMID: 21461650     DOI: 10.1007/s10067-011-1731-4

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  42 in total

Review 1.  Sarcoidosis.

Authors:  Michael C Iannuzzi; Benjamin A Rybicki; Alvin S Teirstein
Journal:  N Engl J Med       Date:  2007-11-22       Impact factor: 91.245

2.  A 65-year-old woman with subcutaneous nodule and hilar adenopathy.

Authors:  Hidenobu Shigemitsu; Corinne A Yarbrough; Shraddha Prakash; Om P Sharma
Journal:  Chest       Date:  2008-11       Impact factor: 9.410

3.  Subcutaneous sarcoidosis worsened by cyclosporin treatment for pyoderma gangrenosum.

Authors:  A Losada; I García-Doval; C de la Torre; M J Cruces
Journal:  Br J Dermatol       Date:  1998-06       Impact factor: 9.302

4.  Subcutaneous sarcoidosis in a patient with malignant carcinoid tumor of the colon.

Authors:  S Weltfriend; Y Harth; I Katz
Journal:  J Am Acad Dermatol       Date:  1989-03       Impact factor: 11.527

5.  Sarcoidosis occurring after interferon-alpha therapy for chronic hepatitis C: report of two cases.

Authors:  Atsushi Hirano; Mikio Kataoka; Yasunari Nakata; Katsuyuki Takeda; Takayuki Kamao; Junichi Hiramatsu; Goro Kimura; Yasushi Tanimoto; Arihiko Kanehiro; Mitsune Tanimoto
Journal:  Respirology       Date:  2005-09       Impact factor: 6.424

6.  Subcutaneous sarcoidosis.

Authors:  D Vainsencher; R K Winkelmann
Journal:  Arch Dermatol       Date:  1984-08

7.  Manifestation of sarcoidosis during interferon and ribavirin therapy for chronic hepatitis C: a report of two cases.

Authors:  Norman Gitlin
Journal:  Eur J Gastroenterol Hepatol       Date:  2002-08       Impact factor: 2.566

8.  Subcutaneous sarcoidosis.

Authors:  E M Higgins; J R Salisbury; A W Du Vivier
Journal:  Clin Exp Dermatol       Date:  1993-01       Impact factor: 3.470

9.  Subcutaneous sarcoidosis with extensive caseation necrosis.

Authors:  Y Kuramoto; Y Shindo; H Tagami
Journal:  J Cutan Pathol       Date:  1988-06       Impact factor: 1.587

10.  Sarcoidosis presenting as cutaneous ulceration, subcutaneous nodules and chronic arthritis.

Authors:  R E Boyd; B S Andrews
Journal:  J Rheumatol       Date:  1981 Mar-Apr       Impact factor: 4.666

View more
  10 in total

1.  Fluorodeoxyglucose PET/CT in subcutaneous sarcoidosis mimicking cutaneous lymphoma.

Authors:  Marcel P M Stokkel; Bernies van der Hiel; Renato Valdés Olmos; Kees Hoefnagel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-05       Impact factor: 9.236

Review 2.  Sarcoidosis and molecular mimicry--important etiopathogenetic aspects: current state and future directions.

Authors:  Georgi Tchernev; Julian Ananiev; José Carlos Cardoso; Uwe Wollina; Shyam B Verma; James W Patterson; Lyubomir A Dourmishev; Michael Tronnier; Hiroyuki Okamoto; Kana Mizuno; Nobuo Kanazawa; Maya Gulubova; Irena Manolova; Cristina Salaro
Journal:  Wien Klin Wochenschr       Date:  2012-04-14       Impact factor: 1.704

3.  Subcutaneous sarcoidosis with underlying intramuscular granuloma.

Authors:  Takenobu Ohashi; Toshiyuki Yamamoto
Journal:  Indian J Dermatol       Date:  2015 Jan-Feb       Impact factor: 1.494

4.  Subcutaneous sarcoidosis: a clinical analysis of nine patients.

Authors:  Masaru Ando; Eishi Miyazaki; Yutaka Hatano; Suehiro Nishio; Chihiro Torigoe; Mari Yamasue; Yutaka Mukai; Shin-Ichi Nureki; Jun-Ichi Kadota
Journal:  Clin Rheumatol       Date:  2016-07-23       Impact factor: 2.980

Review 5.  Extrapulmonary manifestations of sarcoidosis.

Authors:  Deepak A Rao; Paul F Dellaripa
Journal:  Rheum Dis Clin North Am       Date:  2013-03-13       Impact factor: 2.670

6.  [Cutaneous sarcoidosis after treatment with interferon for hepatitis C: A not entirely rare but often overlooked reaction].

Authors:  A Waltschew
Journal:  Pathologe       Date:  2016-03       Impact factor: 1.011

7.  Isolated subcutaneous sarcoid-like granulomatous inflammation occurring at injection sites: 3 patients treated successfully with minocycline.

Authors:  James Abbott; Laura A Taylor; Karolyn A Wanat; Misha Rosenbach
Journal:  JAAD Case Rep       Date:  2017-02-04

8.  Subcutaneous sarcoidosis (Darier-Roussy sarcoidosis) with extensive disease on positron emission tomography: A case report and review of the literature.

Authors:  Paul Youn; Roslyn J Francis; Henry Preston; Fiona Lake
Journal:  Respirol Case Rep       Date:  2022-04-10

9.  Sarcoidosis and chronic hepatitis C: treatment with prednisone and colchicine.

Authors:  Eduardo Guimarães Pereira; Tais Ferreira Guimarães; Caroline Bertolini Bottino; Antonio Macedo D'Acri; Ricardo Barbosa Lima; Carlos José Martins
Journal:  An Bras Dermatol       Date:  2016-04       Impact factor: 1.896

10.  Subcutaneous sarcoidosis: a report of 13 cases and its association with extracutaneous sarcoidosis.

Authors:  Toshiyuki Yamamoto
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2020-06-30       Impact factor: 0.670

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.